Nebius: Why Its Finland Campus Could Hit $650 To $900M Annually — Negative

NBIS   Seeking Alpha — November 24, 2025

Nebius Group reported 3Q25 revenue of $146.1M, up 355% YoY, but missed estimates and posted a $100.4M adjusted net loss. NBIS is rapidly expanding AI infrastructure, highlighted by the Mäntsälä campus scaling to 75MW, potentially generating $650M-$1B in annual recurring revenue. Despite high cash burn and premium valuation multiples, NBIS's long-term growth is anchored by major capacity expansions and strategic deals.

image for news Nebius: Why Its Finland Campus Could Hit $650 To $900M Annually

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against James Hardie Industries plc. (“James Hardie” or the “Company”) (NYSE: JHX) for violations of the federal securities laws on behalf of investors who purchased or acquired James Hardie securities between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”).

image for news Lowey Dannenberg Notifies James Hardie Industries plc. (“James Hardie” or the “Company”) (NYSE: JHX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Ramaco Resources Inc. (NASDAQ: METC) (“Ramaco” or the “Company”) for potential violations of the federal securities laws.

image for news Lowey Dannenberg, P.C. is Investigating Ramaco Resources Inc. (NASDAQ: METC) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NIO Gears Up to Report Q3 Earnings: Here's What to Expect — Positive

NIO   Zacks Investment Research — November 24, 2025

NIO readies its third-quarter results with soaring deliveries and new model launches shaping expectations amid rising operating costs.

image for news NIO Gears Up to Report Q3 Earnings: Here's What to Expect

Distillate Deficit: How DINO is Positioned to Profit From Strong Margins — Positive

DINO   Zacks Investment Research — November 24, 2025

HF Sinclair eyes strong distillate margins as tight diesel and jet fuel supplies, solid utilization and low inventories bolster its refining outlook.

image for news Distillate Deficit: How DINO is Positioned to Profit From Strong Margins

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) for violations of the federal securities laws on behalf of investors who purchased or acquired (i) the common stock of Primo Water Corporation between June 17, 2024 through November 8, 2024, inclusive, and/or (ii) the common stock of Primo Brands between November 11, 2024 through November 6, 2025, inclusive (collectively, the “Class Period”), and were damaged thereby (collectively, the …

image for news Lowey Dannenberg Notifies Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

BELLEVILLE, Ill.--(BUSINESS WIRE)--Illinois American Water announces winners from its “Water Keeps Life Flowing” art contest, showcasing students' creativity & environmental awareness.

image for news Young Artists Make Waves: Illinois American Water Announces 2025 “Water Keeps Life Flowing” Art Contest Winners

Lockheed Martin recovered well from the weak Q2, with execution returning to normal levels and full-year guidance raised. Geopolitical news, especially the Saudi F-35 discussions and new international deals, adds meaningful short-term catalysts. Q3 results showed solid cash flow and margins, with a healthy 1.7x book-to-bill ratio, supporting revenue into 2026.

image for news Lockheed Martin: A 3% Dividend, A Rising Backlog, And Attractive Entry Point (Rating Upgrade)

Carnival vs. Royal Caribbean: Which Cruise Stock Is the Better Buy Now? — Positive

CCL  RCL   Zacks Investment Research — November 24, 2025

CCL's turnaround, record demand and strengthening balance sheet sharpen its edge as investors weigh the cruise sector's next phase.

image for news Carnival vs. Royal Caribbean: Which Cruise Stock Is the Better Buy Now?

AWS announced an investment of up to $50 billion to build AI and supercomputing infrastructure for U.S. government agencies starting in 2026 through a new initiative.

image for news Amazon to invest up to $50B to build AI infrastructure for US government agencies

Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking? — Positive

MO   Zacks Investment Research — November 24, 2025

MO narrows its 2025 EPS outlook as evolving margin trends across key segments point to more measured growth ahead.

image for news Altria Narrows 2025 EPS Outlook: Is Margin Growth Peaking?

Is Broadcom Stock Winning? — Positive

AVGO   Forbes — November 24, 2025

Broadcom‘s stock has increased by 106% in the last year, greatly outshining its competitors amid the AI and data-center surge. But how does this leader in AI infrastructure truly stack up against its elevated valuation?

image for news Is Broadcom Stock Winning?

LOS ANGELES, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 2, 2026.

image for news KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Why the Selloff in Micron Technology Stock Never Made Sense — Neutral

MU   24/7 Wall Street — November 24, 2025

Micron Technology ( NASDAQ:MU ) shares soared to an all-time high of $260 earlier this month, riding the wave of AI-driven optimism in the semiconductor sector.

image for news Why the Selloff in Micron Technology Stock Never Made Sense

3 Stocks to Watch From the Thriving Water Supply Industry — Positive

AWK  AWR  WTRG   Zacks Investment Research — November 24, 2025

In the prospering water supply industry, companies like AWK, WTRG and AWR are poised to benefit from their strong customer base and systematic investments that enable them to serve customers efficiently.

image for news 3 Stocks to Watch From the Thriving Water Supply Industry

Pharma Stock Pops on Wells Fargo Upgrade — Positive

MRK   Schaeffers Research — November 24, 2025

Pharmaceutical stock Merck & Co (NYSE:MRK) is up 4% at $101.64 at last glance, after an upgrade from Wells Fargo to "overweight" from "equal weight," with a price-target hike to $125 from $90.

image for news Pharma Stock Pops on Wells Fargo Upgrade

SMX Subsidiary trueGold Shines After Deal With Gold Industry Giant — Neutral

SMX   Accesswire — November 24, 2025

NEW YORK CITY, NEW YORK / ACCESS Newswire / November 24, 2025 / For centuries, gold has represented permanence, beauty, and wealth. It has been worn as power, traded as currency, and hoarded as security.

image for news SMX Subsidiary trueGold Shines After Deal With Gold Industry Giant

Analysts at Wedbush Securities upgrade Carvana stock to Outperform from Neutral in a research note Monday.

image for news The Auto Market Is in Rough Shape. Buy Carvana Stock Anyway, Analyst Says.

Novo Nordisk shares slide after semaglutide Alzheimer's trial misses primary goal — Negative

NVO   Proactive Investors — November 24, 2025

Shares of Novo Nordisk (NYSE:NVO) fell sharply on Monday after the Danish pharmaceutical giant said a late-stage trial testing its diabetes and weight-loss drug semaglutide in Alzheimer's disease did not meet its main objective. The Phase III Evoke and Evoke+ trials, which enrolled nearly 3,800 patients with early signs of cognitive decline, showed no meaningful impact on disease progression, Novo Nordisk said.

image for news Novo Nordisk shares slide after semaglutide Alzheimer's trial misses primary goal

Can ChatGPT-Powered Shopping Drive Target's Next Digital Push? — Positive

TGT   Zacks Investment Research — November 24, 2025

TGT's new Gen-AI Gift Finder and upcoming ChatGPT shopping aim to boost digital engagement and drive its next growth phase.

image for news Can ChatGPT-Powered Shopping Drive Target's Next Digital Push?